4-(4-(3-((1H-indol-3-yl)methyl)-5-phenyl-1,2,4-triazin-6-yl)benzyl)morpholine

ID: ALA5180818

Chembl Id: CHEMBL5180818

PubChem CID: 164887573

Max Phase: Preclinical

Molecular Formula: C29H27N5O

Molecular Weight: 461.57

Associated Items:

Names and Identifiers

Canonical SMILES:  c1ccc(-c2nc(Cc3c[nH]c4ccccc34)nnc2-c2ccc(CN3CCOCC3)cc2)cc1

Standard InChI:  InChI=1S/C29H27N5O/c1-2-6-22(7-3-1)28-29(23-12-10-21(11-13-23)20-34-14-16-35-17-15-34)33-32-27(31-28)18-24-19-30-26-9-5-4-8-25(24)26/h1-13,19,30H,14-18,20H2

Standard InChI Key:  XGBKJLWLVCHTCR-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5180818

    ---

Associated Targets(Human)

GPR84 Tchem G-protein coupled receptor 84 (1284 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FFAR2 Tchem Free fatty acid receptor 2 (545 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FFAR3 Tchem Free fatty acid receptor 3 (304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 461.57Molecular Weight (Monoisotopic): 461.2216AlogP: 5.11#Rotatable Bonds: 6
Polar Surface Area: 66.93Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.02CX LogP: 5.07CX LogD: 4.92
Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.38Np Likeness Score: -1.03

References

1. Mahindra A, Jenkins L, Marsango S, Huggett M, Huggett M, Robinson L, Gillespie J, Rajamanickam M, Morrison A, McElroy S, Tikhonova IG, Milligan G, Jamieson AG..  (2022)  Investigating the Structure-Activity Relationship of 1,2,4-Triazine G-Protein-Coupled Receptor 84 (GPR84) Antagonists.,  65  (16.0): [PMID:35948061] [10.1021/acs.jmedchem.2c00804]

Source